Second line systemic therapy options for advanced hepatocellular carcinoma; a systematic review.
about
Impact of liver transplantation on the risk of second malignant tumors among hepatocellular carcinoma patients.Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: An updated systematic review of 81 epidemiological studies.Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis.Role of liver-directed local tumor therapy in the management of hepatocellular carcinoma with extrahepatic metastases: a SEER database analysis.The Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma
P2860
Second line systemic therapy options for advanced hepatocellular carcinoma; a systematic review.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Second line systemic therapy o ...... arcinoma; a systematic review.
@en
type
label
Second line systemic therapy o ...... arcinoma; a systematic review.
@en
prefLabel
Second line systemic therapy o ...... arcinoma; a systematic review.
@en
P2860
P1476
Second line systemic therapy o ...... carcinoma; a systematic review
@en
P2093
Mona Fouad
P2860
P304
P356
10.1586/14737140.2015.978295
P577
2014-11-03T00:00:00Z